THANK YOU FOR SUBSCRIBING
Broncus Medical, Inc., developer of diagnostic and therapeutic technology for lung disease, announced the closing of a Series A round of $15 million from Intuitive Surgical, the pioneer and a international technology leader in minimally invasive robotic-assisted surgical treatment.
Checkout This : Medical Care Review
The three-pronged investment from Intuitive includes the equity investment, along with a technology development collaboration, and licensing of Broncus Medical’s intellectual properties, which can be utilized in the development of technologies focused on diagnostic and therapeutic lung procedures.
Stay ahead of the industry with exclusive feature stories on the top companies, expert insights and the latest news delivered straight to your inbox. Subscribe today.
Among Broncus’ existing technology is navigation and procedure planning software and a flexible needle for obtaining lung biopsies. Intuitive Surgical will support Broncus’ continued product development, including the execution of the ongoing EAST 2 (Evaluation of the Archimedes System for Transparenchymal Nodule Access 2) study, a post-market study that will enroll up to 200 patients and is designed to validate performance of the company’s technology for total lung navigation and tumor access. Further, the investment will help fund feasibility studies of Broncus’ investigational technology to bronchoscopically treat lung cancer.
Check Out: Top 10 Medtech Startups
More in News